Storstein L
Clin Pharmacol Ther. 1977 Apr;21(4):395-408. doi: 10.1002/cpt1977214395.
The levels of digitoxin and cardioactive metabolites were measured in 42 atrial biopsies with a 86Rb method modified for analysis of myocardial samples. The mean value was 91.0 ng/gm wet weight (SD 54.4). Myocardial and serum concentrations were compared in 23 patients; there was no significant correlation. The ratio of total drug concentration in myocardium and serum ranged from 1 to 38 with a mean value of 5.4. Calculated from the free drug concentrations, the mean myocardial serum ratio was 200, which reflects the high affinity of digitoxin and cardioactive metabolites to the myocardium. The metabolic pattern of cardioactive and inactive metabolites (conjugates with glucuronic and sulfuric acid) was studied in autopsy samples from left ventricular myocardium from 7 patients. Significant differences between the myocardial and serum patterns of cardioactive and inactive metabolites were demonstrated. The myocardium contained less unchanged digitoxin (25.7%) and more hydrolyzed (55.4%) and conjugated (54.1%) metabolites than serum (57.6%, 31.0%, and 33.1%, respectively). Hydroxylated metabolites in myocardium (15.8%) were not significantly changed compared to serum (10.0%).
采用一种为分析心肌样本而改良的⁸⁶Rb方法,对42份心房活检样本中的洋地黄毒苷和具有心脏活性的代谢产物水平进行了测定。平均值为91.0 ng/g湿重(标准差54.4)。对23例患者的心肌和血清浓度进行了比较;未发现显著相关性。心肌与血清中总药物浓度之比在1至38之间,平均值为5.4。根据游离药物浓度计算,心肌与血清的平均比值为200,这反映了洋地黄毒苷和具有心脏活性的代谢产物对心肌的高亲和力。对7例患者左心室心肌尸检样本中具有心脏活性和无活性代谢产物(与葡萄糖醛酸和硫酸结合物)的代谢模式进行了研究。结果显示,具有心脏活性和无活性代谢产物的心肌模式与血清模式之间存在显著差异。与血清(分别为57.6%、31.0%和33.1%)相比,心肌中未改变的洋地黄毒苷含量较少(25.7%),水解代谢产物(55.4%)和结合代谢产物(54.1%)含量较多。心肌中的羟基化代谢产物(15.8%)与血清(10.0%)相比无显著变化。